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This year for CS Mantech, DARPA’s John
Zolper co-authored on integrated micro
systems as the next technology transition.
Highlighted is the fact that it is circuit level
capability, measured by speed, power and
precision that is ‘king,’ rather than simply
device level performance. 
The work to achieve this is not insignifi-
cant. Vitesse’s InP circuit performance
achievement (page 34) has not only
required device redesign, but a purpose
built processing line.
“And as CMOS scaling and integration are
considered – systems containing a trillion
transistors, dissipating less than 100W
(about the complexity of the human brain)
the vision is of the integrated microsystem
and the 3D circuit – heterogenous integra-
tion; volumetric system scaling; VLSI of
photonic and optoelectronic components
into traditional CMOS circuits.”
“Researchers are using MEMS techniques
to produce arrays of nano-resonators that
can be integrated with other components
in silico” and “DARPA has launched a
major initiative to develop supporting
technologies to start the revolution of the
integrated Microsystems.” Sematech has
been quick to add 3D interconnects to its
top technical challenges for 2005. 
But as the Semiconductor Industry
Association reports record sales – a 2004
growth of 28.6% with $214bn, surpassing
the $204bn of 2000 – an ominous if less
publicised problem lurks behind such fore-
casts.  It is that both US and European top
researchers report that R&D funds are at
an all time low. The suggestion that this
changes if “nanotechnology” can be
attached to projects, draws a wry look. 
John E. Kelly III, senior VP and group exec
of the IBM Technology Group puts it suc-
cinctly, with a slant that is as valid for
Europe. “State-of-the-art, 300mm fabs
with 90nm process technology are coming
on line in other parts of the world. No one
doubts that the links between R&D and
manufacturing are becoming more impor-
tant, these links are dynamic, and proximi-
ty between labs and fabs is also an issue. 
Because US semiconductor R&D efforts
currently face an annual shortfall of
approximately $1.5bn, Kelly is urging SIA
members to bring investments in line to
stay current with the CMOS technology
roadmap, as well as to extending technol-
ogy beyond CMOS.
“Public policy must not only encourage
R&D activities in the US, but also provide
an attractive climate for investing in pro-
duction capacity in the US,” noted Kelly.
“Constant innovation is the key to being
competitive while paying high wages to
our workforce.”
If R&D falls by the wayside, there’s 
a deeper worry factor and that’s the sec-
tor’s appeal to the student and the ability
of the Universities to gear sufficiently mul-
tidisciplinary courses to equip the next
work force for the nano, compound and
silicon revolutions.
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